Assessing a Novel Virtual Environment That Assists With Activities of Daily Living
2 other identifiers
interventional
38
1 country
2
Brief Summary
This Phase 1 study looks at how a new videogame-based program can help residents and care partners prepare for ADLs in a fun way with minimal risk, potentially reducing escalating problems associated with ADL completions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2022
CompletedStudy Start
First participant enrolled
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedResults Posted
Study results publicly available
February 10, 2025
CompletedFebruary 10, 2025
January 1, 2025
1.2 years
May 31, 2022
December 20, 2024
January 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- Severe)
The ADCS-ADL assesses the competence of patients with Alzheimer's Disease (AD) in basic and instrumental activities of daily living (ADLs). It can be completed by a caregiver in questionnaire format, or administered by a clinician/researcher as a structured interview with a caregiver. There are 19 questions. The minimum and maximum values are 0 - 54. A higher score means a better outcome.
6 weeks
The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The Minimum and Maximum Values Are A Higher Score Means a Better or Worse Outcome.
The NPI-NH The NPI-NH has been used to characterize the psychopathology of patients in nursing homes as well as to measure the impact of anti dementia and psychotropic drugs and behavioral changes in dementia patients dwelling in nursing homes. There are questions. The minimum and maximum values are 12 - 120 A lower score means a better outcome.
6 weeks
Secondary Outcomes (3)
Approaches to Dementia Questionnaire (ADQ)
6 weeks
Sense of Competence in Dementia Care Staff (SCIDS) Scale
6 weeks
The Copenhagen Burnout Index
6 weeks
Study Arms (1)
Persons residing in long-term care homes
EXPERIMENTALSubjects' ADLs are studied with intervention compared to baseline (without intervention).
Interventions
A videogame-generated virtual world designed for the AD/ADRD care dyad.
Eligibility Criteria
You may qualify if:
- The subject will have a diagnosis of AD/ADRD, or symptoms of an undiagnosed AD/ADRD as observed by professional care staff and confirmed by the head of clinical care. The investigators will neither include nor exclude participation based on cognitive test scores. The subject will have had challenge(s) completing one or more ADLs in the previous month, as discussed at staff meetings, referenced in care plans, or observed/experienced by direct care staff.
- Other specifications:
- Understand English or Russian.
- Can sit comfortably for at least 15 minutes in a chair/wheelchair at a table or propped up in bed or princess chair with a tray table
- Are not known to be in pain
- Have good vision, or good corrected vision (i.e., glasses)
- Have good hearing, or good corrected hearing (i.e., aids)
- May sometimes have anxiety or agitation when undertaking ADLs.
You may not qualify if:
- Ineligible subjects are those with significant non-AD/ADRD neurological, psychiatric, or physical impairment or those who are totally dependent upon others for ADLs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- mandylead
- National Institute on Aging (NIA)collaborator
Study Sites (2)
Bruceville Point Senior Living Community
Elk Grove, California, 95757, United States
Elder Ashram
Oakland, California, 94602, United States
Related Publications (3)
Quail Z, Bolton L, Massey K. Digital delivery of non-pharmacological intervention programmes for people living with dementia during the COVID-19 pandemic. BMJ Case Rep. 2021 Jun 17;14(6):e242550. doi: 10.1136/bcr-2021-242550.
PMID: 34140328BACKGROUNDKahle-Wrobleski K, Coley N, Lepage B, Cantet C, Vellas B, Andrieu S; Plasa DSA Group. Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factors. Curr Alzheimer Res. 2014 May;11(4):357-66. doi: 10.2174/1567205011666140317101419.
PMID: 24635843BACKGROUNDBourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, Konig A, Robert P. Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type. J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.
PMID: 26728933BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Length of study reduced from 8 to 6 weeks due to staff participants' lack of adherence. Reasons: roster changes and absenteeism.
Results Point of Contact
- Title
- Dr Mandy Salomon
- Organization
- Mentia
Study Officials
- PRINCIPAL INVESTIGATOR
Mandy Salomon, PhD
Mentia DTx
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief Scientific Officer
Study Record Dates
First Submitted
May 31, 2022
First Posted
June 14, 2022
Study Start
June 9, 2022
Primary Completion
August 30, 2023
Study Completion
October 30, 2023
Last Updated
February 10, 2025
Results First Posted
February 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share